Contents:

Contributors Preface 1 Smoking Cessation 2 Lung Cancer Susceptibility Genes 3 Lung Cancer Susceptibility and Risk Assessment Models 4 The Molecular Genetics of Lung Cancer 5 Molecular Biology of Preneoplastic Lesions of the Lung 6 Detection of Preneoplastic Lesions 7 Treatment of Preneoplastic Lesions of the Lung 8 The Pathology and Pathogenesis of Peripheral Lung Adenocarcinoma Including Bronchioloalveolar Carcinoma 9 Treatment of Bronchioloalveolar Carcinoma 10 Molecular Profiling for Early Detection and Prediction of Response in Lung Cancer 11 The Role for Mediastinoscopy in the Staging of Nonsmall Cell Lung Cancer 12 Minimally Invasive Surgery for Lung Cancer 13 Extended Resections for Lung Cancer 14 Adjuvant Chemotherapy Following Surgery for Lung Cancer 15 Induction Chemotherapy for Resectable Lung Cancer 16 Image-Guided Radiation Therapy 17 Stereotactic Body Radiation Therapy for Lung Cancer 18 Proton Therapy 19 Combinations of Radiation Therapy and Chemotherapy for Nonsmall Cell Lung Carcinoma 20 New Chemotherapeutic Agents in Lung Cancer 21 Immunologic Approaches to Lung Cancer Therapy 22 Epidermal Growth Factor Receptor Inhibitors 23 Tumor Angiogenesis: Biology and Therapeutic Implications for Lung Cancer 24 Retinoids and Rexinoids in Lung Cancer Prevention and Treatment 25 Proteasome Inhibition in Nonsmall Cell Lung Cancer Therapy 26 Targeted Genetic Therapy for Lung Cancer 27 Screening for Early Detection 28 Natural Agents for Chemoprevention of Lung Cancer Index

Author

Jack A. Roth, MD FACS, Professor and Chairman, Bud Johnson Clinical Distinguished Chair, The University of Texas M.D. Anderson Cancer Center, Department of Thoracic & Cardiovascular Surgery and Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Cancer Gene Therapy, Houston, Texas, USA. James D. Cox, MD, Professor and Head, Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. Waun Ki Hong, MD, American Cancer Society Clinical Research Professor, Charles A. LeMistre Distinguished Chair in Thoracic Oncology and Professor and Chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.